Hepatitis B is a severe disease caused by a virus which particularly attacks the liver. The virus is termed as hepatitis B virus (HBV), and it is capable of causing prolonged infection, liver cancer, cirrhosis, liver failure and eventually death. Hepatitis is transmitted or inherited when semen, blood, and/or any other bodily fluids from a person who has been infected with the hepatitis B virus gets introduced to a healthy person’s body. Hepatitis B is either acute or shorter for a few people and for a few others it is a prolonged chronic infection. It has been said that approximately 90% of infected infants become chronically infected as compared to 2% to 6% of the adults. The only best way to prevent this virus is by getting vaccinated and the hepatitis B vaccine is available for all age groups. The hepatitis B vaccine comprises of viral envelope proteins and hepatitis B surface antigens (HBsAg). The vaccines are developed by making use of yeast cells and the course of medication includes two or three injections. All of these injections are given at an equal time interval and the first and the second doses give complete protection against the infection and the last injection is administered in order to prolong the effect of hepatitis B vaccine. The vaccination helps in building up an immune system in the patient’s body which creates an antibody to HBsAg (anti-HBs).
Top Manufactures Analysis of Hepatitis B Vaccine: GSK, Merck, Sanofi-Pasteur, Novartis, BE, CSL Behring
To Browse Complete Report, Click Here: http://www.qyresearchgroups.com/report/global-hepatitis-b-vaccine-sales-market-report-2016
The global hepatitis B vaccine market was valued approximately at US $959.9 million in 2012 and is anticipated to nearly touch US $1.19 billion by the end of 2022, growing a substantial CAGR of 2.2% during the forecast period. The global market of this industry is escalating at a significantly high rate owing to the rise in number of patients acquiring the hepatitis B infection. Furthermore, budding population rate and increased awareness for enhanced medical care facilities is propelling the overall market. Several types of hepatitis B vaccines are present in the market and one such kind of the recombinant DNA vaccines which is developed by the interpolated by HBV. The HBV drugs which are available in the market for the patients who have been infected by this virus have not yet proven to be effective in arresting the infection and therefore prevention with the help of the vaccines gain more significance; this awareness amongst the global population is one of the key factors contributing towards the growth of this industry. Several governments are taking proactive initiatives in the awareness programs which are helping the market flourish. However, high cost, lack of people’s consent towards getting vaccinated, and shortage of vaccines in certain developing countries are factors which are being a barrier for the growth of this market on a global level.
To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/155766
Geographically, North America leads the global hepatitis B vaccines market owing to the occurrence of hepatitis B infection cases and enhanced medical care facilities. Following this region, is Asia Pacific and Europe which are predicted to witness lucrative growth during the forecast period. In Asia Pacific region, the market of India and China are anticipated to garner more profit and grow rapidly in the near future because of abundant investments by key industry players of these countries. Some of the major industry players of the global hepatitis B vaccines market are GSk, Merck, Sanofi-Pasteur, Novartis, BE, CSL Behring, LG Life Sciences, Crucell, Berna, TIANTAN BIO, BIO KANGTAI, Hissen, NCPC GeneTech, and HUALAN BIO.
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world’s most complete and current database of expert insights on global industries, companies, products, and trends.
Room B1510, ShijiKemao Building, No.66, Zhongguancun East Road,
Haidian District, Beijing, 100190, China